Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clark C Chen

Showing results (291-300 of 296) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 296 results.
Cancer Drug Resistance (Alhambra, Calif.)|June 13, 2025
Acquired resistance to molecularly targeted therapies for cancerNolan M Stubbs, Tyler J Roady, Maximilian P Schwermann, et al.
Frontiers in Oncology|April 2, 2025
IGV-001 cellular immunotherapy for newly diagnosed glioblastoma: overcoming the logistic challengeEric T Wong, Deus Cielo, Konstantina Svokos, et al.
Cell Stem Cell|January 21, 2020
Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin α<sub>v</sub>β<sub>5</sub> AxisZhe Zhu, Pinar Mesci, Jean A Bernatchez, et al.
Nature Medicine|July 21, 2025
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trialFarshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Nature Medicine|May 15, 2023
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trialFarshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Journal of Extracellular Vesicles|September 1, 2015
Meeting report: discussions and preliminary findings on extracellular RNA measurement methods from laboratories in the NIH Extracellular RNA Communication ConsortiumLouise C Laurent, Asim B Abdel-Mageed, P David Adelson, et al.
Pageof 30

Showing results (291-300 of 296) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 296 results.
Cancer Drug Resistance (Alhambra, Calif.)|June 13, 2025
Acquired resistance to molecularly targeted therapies for cancerNolan M Stubbs, Tyler J Roady, Maximilian P Schwermann, et al.
Frontiers in Oncology|April 2, 2025
IGV-001 cellular immunotherapy for newly diagnosed glioblastoma: overcoming the logistic challengeEric T Wong, Deus Cielo, Konstantina Svokos, et al.
Cell Stem Cell|January 21, 2020
Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin α<sub>v</sub>β<sub>5</sub> AxisZhe Zhu, Pinar Mesci, Jean A Bernatchez, et al.
Nature Medicine|July 21, 2025
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trialFarshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Nature Medicine|May 15, 2023
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trialFarshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Journal of Extracellular Vesicles|September 1, 2015
Meeting report: discussions and preliminary findings on extracellular RNA measurement methods from laboratories in the NIH Extracellular RNA Communication ConsortiumLouise C Laurent, Asim B Abdel-Mageed, P David Adelson, et al.
Pageof 30